(Q73297911)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

1 reference

randomized experiment

1 reference

C Caffarelli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

L G Sensi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

F Marcucci

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Cavagni

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1142-1147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117271%20AND%20SRC:MED&resulttype=core&format=json

Allergen immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997

2 November 2019

uses

randomized experiment

0 references

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

1 reference

7 January 2021

Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

The effect of short-term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secretions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

Decrease of allergen-specific T-cell response induced by local nasal immunotherapy.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

Allergic rhinitis in children: effects of flunisolide and disodium cromoglycate on nasal eosinophil cationic protein

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

A potential vaccine strategy for asthma and allied atopic diseases during early childhood.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

Sublingual immunotherapy for allergic respiratory disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

Sublingual allergen administration. I. Selective suppression of IgE production in rats by high allergen doses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

Reactivity of monoclonal antibodies EG1 and EG2 with eosinophils and their granule proteins.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00655.X

7 January 2021

10.1034/J.1398-9995.2000.00655.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference